rhein has been researched along with n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Gong, T; Jiang, J; Li, J; Sun, X; Zhang, J; Zhang, Z | 1 |
1 other study(ies) available for rhein and n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
| Article | Year |
|---|---|
Dual pancreas- and lung-targeting therapy for local and systemic complications of acute pancreatitis mediated by a phenolic propanediamine moiety.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Cell Line; Cell Survival; HeLa Cells; Hep G2 Cells; Humans; Interleukin-6; Iodobenzenes; Lung; Male; Pancreas; Pancreatitis; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2015 |